SCHEMBL30712948

CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.66

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	6/20	0.66

▸	IL23R	Q5VWK5	11/20	0.64

▸	CCKBR	P32239	1/20	0.62

▸	NR3C1	P04150	2/20	0.62

▸	ECE1	P42892	1/20	0.61

▸	MUS81	Q96NY9	1/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL35210884	0.91	GLP1R (0.64)	GLP1RIL23RCCKBRNR3C1ECE1
SCHEMBL30625832	0.89	GLP1R (0.68)	GLP1RCCKBRECE1MUS81
SCHEMBL30567715	0.88	GLP1R (0.62)	GLP1RIL23RCCKBR
SCHEMBL30607410	0.88	IL23R (0.66)	GLP1RIL23RCCKBR
SCHEMBL31230578	0.88	CCKBR (0.59)	GLP1RIL23RCCKBR
SCHEMBL30567741	0.88	NR3C1 (0.72)	GLP1RIL23RCCKBRNR3C1ECE1
SCHEMBL30712980	0.88	GLP1R (0.69)	GLP1RIL23RCCKBR
SCHEMBL29417283	0.88	GLP1R (0.66)	GLP1RIL23RNR3C1ECE1MUS81
SCHEMBL31182605	0.88	GLP1R (0.68)	GLP1RIL23RCCKBRNR3C1ECE1
SCHEMBL30712897	0.87	IL23R (0.59)	GLP1RIL23RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240003881-A1	SYSTEM AND METHOD FOR RAPID AND SENSITIVE DETECTION OF ANTI-PATHOGEN ANTIBODIES	THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA)	2024-01-04	—	—	US	disclosed